Author Correction: Conversion of human fibroblasts to angioblast-like progenitor cells (Nature Methods, (2013), 10, 1, (77-83), 10.1038/nmeth.2255);Conversion of human fibroblasts to angioblast-like progenitor cells

Nature Methods

Volumn 10, Issue 1, 2013, Pages 77-83

  Kurian, Leo ^a   Sancho Martinez, Ignacio ^a   Nivet, Emmanuel ^a   Aguirre, Aitor ^a   Moon, Krystal ^a   Pendaries, Caroline ^b   Volle Challier, Cecile ^b   Bono, Francoise ^b   Herbert, Jean Marc ^b   Pulecio, Julian ^c   Xia, Yun ^a   Li, Mo ^a   Montserrat, Nuria ^c   Ruiz, Sergio ^a   Dubova, Ilir ^a   Rodriguez, Concepcion ^a   Denli, Ahmet M ^a   Boscolo, Francesca S ^d,e   Thiagarajan, Rathi D ^d,e   Gage, Fred H ^a   Loring, Jeanne F ^d   Laurent, Louise C ^d,e   Izpisua Belmonte, Juan Carlos ^a,c   more..

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SANOFI   (France)

^c CENTER OF REGENERATIVE MEDICINE IN BARCELONA   (Spain)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; FIBROBLAST; HEMANGIOBLAST; HUMAN; HUMAN CELL; IN VIVO STUDY; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL;

EID: 84871977315     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/s41592-020-0745-8     Document Type: Erratum

References (30)

1. Sancho-Martinez, I., Nivet, E. & Izpisua Belmonte, J.C. The labyrinth of nuclear reprogramming. J. Mol. Cell Biol. 3, 327-329 (2011).
2. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
3. Laiosa, C.V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L. & Graf, T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25, 731-744 (2006).
4. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
5. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
6. Vierbuchen, T. & Wernig, M. Direct lineage conversions: Unnatural but useful? Nat. Biotechnol. 29, 892-907 (2011).
7. Efe, J.A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215-222 (2011).
8. Kim, J. et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. USA 108, 7838-7843 (2011).
9. Sancho-Martinez, I., Baek, S.H. & Izpisua Belmonte, J.C. Lineage conversion methodologies meet the reprogramming toolbox. Nat. Cell Biol. 14, 892-899 (2012).
10. Papp, B. & Plath, K. Reprogramming to pluripotency: Stepwise resetting of the epigenetic landscape. Cell Res. 21, 486-501 (2011).
11. Plath, K. & Lowry, W.E. Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Genet. 12, 253-265 (2011).
12. Goldman, O. et al. A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27, 1750-1759 (2009).
13. Dzierzak, E. & Speck, N.A. Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat. Immunol. 9, 129-136 (2008).
14. Choi, K.D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559-567 (2009).
15. James, D. et al. Expansion and maintenance of human embryonic stem cellYderived endothelial cells by TGFβ inhibition is Id1 dependent. Nat. Biotechnol. 28, 161-166 (2010).
16. Levenberg, S., Ferreira, L.S., Chen-Konak, L., Kraehenbuehl, T.P. & Langer, R. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat. Protoc. 5, 1115-1126 (2010).
17. Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376-388 (2011).
18. Subramanyam, D. et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29, 443-448 (2011).
19. Narazaki, G. et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498-506 (2008).
20. Cheung, C., Bernardo, A.S., Trotter, M.W., Pedersen, R.A. & Sinha, S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat. Biotechnol. 30, 165-173 (2012).
21. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409-412 (2011).
22. Chan, E.M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27, 1033-1037 (2009).
23. Ohta, T., Ito, S. & Nakazato, Y. All-or-nothing responses to carbachol in single intestinal smooth muscle cells of rat. Br. J. Pharmacol. 112, 972-976 (1994).
24. Kohda, M., Komori, S., Unno, T. & Ohashi, H. Carbachol-induced [Ca2+]i oscillations in single smooth muscle cells of guinea-pig ileum. J. Physiol. (Lond.) 492, 315-328 (1996).
25. Yamanaka, S. Induced pluripotent stem cells: Past, present, and future. Cell Stem Cell 10, 678-684 (2012).
26. Yusa, K. et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391-394 (2011).
27. Ginsberg, M. et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression. Cell 151, 559-575 (2012).
28. Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357 (2009).
29. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284 (2008).
30. Ludwig, T.E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187 (2006).